patent/JP-H05310672-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05310672-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-23
filingDate	1993-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ede08fdb9cf1835d8271eb0b1c39f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4d707879c695cfb7b1661edf1f97bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e98a8a7152d480f3ad8c54d963563a20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1be00413310b81663ad568aea636c0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ab6ea053069e06ef3dad592234d02df
publicationDate	1993-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	JP-H05310672-A
titleOfInvention	Novel 2-cyano-3-hydroxyenamides, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments
abstract	(57) [Summary] (Corrected) [Configuration] [For example, 2-cyano-3-hydroxy-4-methyl- N- (4-trifluoromethylphenyl) penta-2, 4-dienamide], a process for producing the same, and a pharmaceutical composition containing them. [Effect] The above compound can be used for the treatment of rheumatoid arthritis, immune or non-immune chronic inflammatory diseases and cancer.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004085383-A1
priorityDate	1992-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234611370 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76185068

Total number of triples: 30.